• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

旅行者腹泻——不同预防措施的利弊。

Travellers' diarrhoea - pros and cons of different prophylactic measures.

机构信息

Institute of Specific Prophylaxis and Tropical Medicine, Medical University Vienna, Vienna, Austria.

出版信息

Wien Klin Wochenschr. 2009 Oct;121 Suppl 3:13-8. doi: 10.1007/s00508-009-1228-1.

DOI:10.1007/s00508-009-1228-1
PMID:19915810
Abstract

Travellers' diarrhoea is the most likely cause for disturbing travel arrangements. At an average, 30-40% of tourists are concerned, depending on the travel destination. Due to the high impact on the travellers' health this topic is still of utmost importance in travel medicine. A wide spectrum of enteropathogens can be accountable, with enterotoxigenic Escherichia coli being the major causing pathogen among other bacteria, parasites and viruses. Here we discuss advantages and disadvantages of different prophylactic measures against travellers' diarrhoea. The effectiveness but also the relevance of hygiene education, vaccination and antibiotic or probiotic application will be discussed in the context of the travellers' different risk profiles.

摘要

旅行者腹泻是扰乱旅行安排的最可能原因。根据旅行目的地的不同,平均有 30%-40%的游客会受到影响。由于其对旅行者健康的巨大影响,这个问题在旅行医学中仍然至关重要。一系列肠道病原体都可能导致这种疾病,产肠毒素性大肠杆菌是除其他细菌、寄生虫和病毒之外的主要病原体。在这里,我们讨论了针对旅行者腹泻的不同预防措施的优缺点。我们将根据旅行者的不同风险概况讨论卫生教育、疫苗接种以及抗生素或益生菌应用的有效性和相关性。

相似文献

1
Travellers' diarrhoea - pros and cons of different prophylactic measures.旅行者腹泻——不同预防措施的利弊。
Wien Klin Wochenschr. 2009 Oct;121 Suppl 3:13-8. doi: 10.1007/s00508-009-1228-1.
2
Systematic review: prevention of travellers' diarrhoea.系统评价:旅行者腹泻的预防
Aliment Pharmacol Ther. 2008 May;27(9):741-51. doi: 10.1111/j.1365-2036.2008.03647.x. Epub 2008 Feb 14.
3
Previous exposure in a high-risk area for travellers' diarrhoea within the past year is associated with a significant protective effect for travellers' diarrhoea: a prospective observational cohort study in travellers to South Asia.过去一年内在旅行者腹泻高风险地区的既往暴露与旅行者腹泻有显著的保护作用相关:一项针对前往南亚旅行者的前瞻性观察性队列研究。
J Travel Med. 2017 Sep 1;24(5). doi: 10.1093/jtm/tax056.
4
Travellers' diarrhoea: contemporary approaches to therapy and prevention.旅行者腹泻:当代治疗与预防方法
Drugs. 2006;66(3):303-14. doi: 10.2165/00003495-200666030-00003.
5
Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS.口服霍乱疫苗WC/rBS预防旅行者腹泻的有效性
Travel Med Infect Dis. 2007 Nov;5(6):380-4. doi: 10.1016/j.tmaid.2007.06.001. Epub 2007 Jul 30.
6
Travellers' diarrhoea and the effect of pre-travel health advice in general practice.旅行者腹泻及全科医疗中旅行前健康建议的效果
Br J Gen Pract. 1997 Feb;47(415):71-5.
7
Analysis of Escherichia coli isolates from subjects with travellers' diarrhoea using DNA probes and serotyping.使用DNA探针和血清分型法对旅行者腹泻患者分离出的大肠杆菌进行分析。
Eur J Clin Microbiol Infect Dis. 1991 Aug;10(8):625-9. doi: 10.1007/BF01975813.
8
Travellers' diarrhoea.旅行者腹泻
Int J Antimicrob Agents. 2003 Feb;21(2):116-24. doi: 10.1016/s0924-8579(02)00282-0.
9
Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.使用含有大肠杆菌不耐热毒素的贴片预防旅行者腹泻:一项II期随机双盲安慰剂对照现场试验。
Lancet. 2008 Jun 14;371(9629):2019-25. doi: 10.1016/S0140-6736(08)60839-9.
10
Systematic review: the epidemiology and clinical features of travellers' diarrhoea.系统评价:旅行者腹泻的流行病学和临床特征。
Aliment Pharmacol Ther. 2009 Aug;30(3):187-96. doi: 10.1111/j.1365-2036.2009.04028.x. Epub 2009 Apr 21.

引用本文的文献

1
U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge.布鲁氏菌 U-Omp19 增强了 dmLT 的免疫原性,提高了对大肠杆菌不耐热肠毒素(LT)口服攻毒的保护作用。
Vaccine. 2020 Jul 6;38(32):5027-5035. doi: 10.1016/j.vaccine.2020.05.039. Epub 2020 Jun 11.
2
Statement on Older Travellers: Committee to Advise on Tropical Medicine and Travel.关于老年旅行者的声明:热带医学与旅行咨询委员会
Can Commun Dis Rep. 2011 Jul 21;37(ACS-2):1-24. doi: 10.14745/ccdr.v37i00a02.
3
Travelers' Diarrhea: A Clinical Review.

本文引用的文献

1
Reduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers, Finland.芬兰旅行者分离出的肠炎沙门氏菌中氟喹诺酮敏感性降低。
Emerg Infect Dis. 2009 May;15(5):809-12. doi: 10.3201/eid1505.080849.
2
Campylobacteriosis in Austria: situation and trends.奥地利的弯曲杆菌病:现状与趋势
Wien Klin Wochenschr. 2009;121(3-4):103-7. doi: 10.1007/s00508-008-1129-8.
3
The impact of probiotic on gut health.益生菌对肠道健康的影响。
旅行者腹泻:临床综述
Recent Pat Inflamm Allergy Drug Discov. 2019;13(1):38-48. doi: 10.2174/1872213X13666190514105054.
4
Chemoprophylaxis of Tropical Infectious Diseases.热带传染病的化学预防
Pharmaceuticals (Basel). 2010 May 18;3(5):1561-1575. doi: 10.3390/ph3051561.
5
Pathogen-induced secretory diarrhea and its prevention.病原体诱导的分泌性腹泻及其预防。
Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1721-1739. doi: 10.1007/s10096-016-2726-5. Epub 2016 Jul 29.
6
Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.预防产肠毒素大肠杆菌(ETEC)腹泻的疫苗。
Cochrane Database Syst Rev. 2013 Jul 5;2013(7):CD009029. doi: 10.1002/14651858.CD009029.pub2.
7
Clinical implications of enteroadherent Escherichia coli.肠道黏附性大肠杆菌的临床意义
Curr Gastroenterol Rep. 2012 Oct;14(5):386-94. doi: 10.1007/s11894-012-0277-1.
8
Immunization in travel medicine.旅行医学中的免疫接种。
Prim Care. 2011 Dec;38(4):643-79, viii. doi: 10.1016/j.pop.2011.07.005.
Curr Drug Metab. 2009 Jan;10(1):68-78. doi: 10.2174/138920009787048437.
4
Prophylactic immunisation against traveller's diarrhoea caused by enterotoxin-forming strains of Escherichia coli and against cholera: does it make sense and for whom?针对由产肠毒素大肠杆菌菌株引起的旅行者腹泻以及霍乱的预防性免疫:是否有意义以及适用于哪些人?
Travel Med Infect Dis. 2008 Nov;6(6):362-7. doi: 10.1016/j.tmaid.2006.05.003.
5
Gastrointestinal infection among international travelers globally.全球国际旅行者中的胃肠道感染
J Travel Med. 2008 Jul-Aug;15(4):221-8. doi: 10.1111/j.1708-8305.2008.00203.x.
6
Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera.接种杜科瑞疫苗预防旅行者腹泻(产毒性大肠杆菌)和霍乱。
Expert Rev Vaccines. 2008 Jul;7(5):561-7. doi: 10.1586/14760584.7.5.561.
7
Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.使用含有大肠杆菌不耐热毒素的贴片预防旅行者腹泻:一项II期随机双盲安慰剂对照现场试验。
Lancet. 2008 Jun 14;371(9629):2019-25. doi: 10.1016/S0140-6736(08)60839-9.
8
Passenger behaviors associated with norovirus infection on board a cruise ship--Alaska, May to June 2004.2004年5月至6月阿拉斯加一艘游轮上与诺如病毒感染相关的乘客行为
J Travel Med. 2008 May-Jun;15(3):177-83. doi: 10.1111/j.1708-8305.2008.00200.x.
9
Lactobacilli antagonize biological effects of enterohaemorrhagic Escherichia coli in vitro.乳酸杆菌在体外拮抗肠出血性大肠杆菌的生物学效应。
Lett Appl Microbiol. 2008 Jun;46(6):613-9. doi: 10.1111/j.1472-765X.2008.02363.x. Epub 2008 Apr 18.
10
Systematic review: prevention of travellers' diarrhoea.系统评价:旅行者腹泻的预防
Aliment Pharmacol Ther. 2008 May;27(9):741-51. doi: 10.1111/j.1365-2036.2008.03647.x. Epub 2008 Feb 14.